Supaveda · Ingredient Spotlight
Triphala
Tri = Three · Phala = Fruits · The Tridoshic Rasayana
Amalaki · Bibhitaki · Haritaki — equal parts, inseparable whole
Triphala is not a herb. It is a formula — perhaps the most important, most studied, and most universally applicable formula in the entire Ayurvedic pharmacopoeia. The name says everything: tri (three) + phala (fruits). Three carefully chosen fruits, combined in equal measure, producing a therapeutic whole that consistently exceeds the sum of its extraordinary parts.
For over 5,000 years, Ayurvedic physicians have prescribed Triphala as the foremost Tridoshic Rasayana — a rejuvenative tonic suitable for all constitutions (Prakriti), all ages, and all seasons. No other formula or single herb in Ayurveda holds this designation. It is classified in the Charaka Samhita as Pathyam — "that which is beneficial to all paths" — and in its most simple daily use, it has been described as the single formula most capable of maintaining health and preventing disease if taken regularly throughout life. 1
A PMC-indexed systematic review (Baliga et al., 2012) and a 2025 update in International Journal of Physiology, Pathophysiology and Pharmacology have now confirmed over twenty distinct pharmacological activities for Triphala — from digestive and immunomodulatory effects confirmed in human clinical trials, to antioxidant, radioprotective, and gut microbiome-modulating properties validated in rigorous preclinical studies. 12
Triphala is a Formula — Why This Matters
Unlike the single-herb blogs in this series, Triphala is a classical compound preparation — each of its three component fruits is a medicine in its own right, but combined in the traditional 1:1:1 ratio, they produce synergistic effects that exceed what any single fruit achieves alone. Peer-reviewed research has confirmed this synergy: Triphala consistently outperforms its individual constituents in antioxidant, anticancer, and radioprotective assays. 3 Understanding each of the three fruits independently is the key to understanding why the combination is so powerful — see the Three Fruits section below.
At a Glance — Key Evidence-Backed Benefits
The Three Fruits — Each a Medicine in Its Own Right
The three fruits of Triphala are chosen with extraordinary precision. Each corresponds to a different dosha, a different phase of digestion, a different stage of life, and a different tissue system — yet together they cover the entire spectrum of health. No substitution or variation in ratio is recognised in classical Ayurveda: the 1:1:1 formula is considered essential to achieve the tridoshic balance the formula is famous for. 1
- Richest plant source of Vitamin C — heat-stable ascorbic acid complex
- Primary antioxidant of Triphala — emblicanins A & B unique to Amla
- Liver-protective and cholesterol-lowering
- Vision support; classical Chakshushya (eye tonic)
- Governs the "nourishing" phase of digestion
- Strongest respiratory and bronchial herb of the three
- Antimicrobial — active against respiratory pathogens
- Lipid-lowering — beta-sitosterol and gallic acid reduce LDL
- Antifungal and antiparasitic properties confirmed
- Governs the "absorbing" phase of digestion
- Primary laxative action — chebulosides stimulate bowel motility
- Richest source of chebulinic acid → urolithin A via gut microbiota
- Five tastes present simultaneously — Panchakarma Rasa
- Anticancer preclinical activity — most studied of the three
- Governs the "elimination" phase of digestion
1 + 1 + 1 = More Than 3: The Synergy Principle
Multiple peer-reviewed studies have confirmed what classical Ayurveda always maintained: Triphala as a combined formula consistently outperforms its individual constituents. In antioxidant assays, radioprotective models, and anticancer cell studies, the combination achieves results that neither Amalaki, Bibhitaki, nor Haritaki achieves alone at equivalent doses. 34
Why the Combination Outperforms the Parts
Traditional Ayurvedic Uses & Classification
Triphala's designation as a Tridoshic Rasayana — a rejuvenative formula that pacifies all three doshas simultaneously — is extraordinary in classical Ayurveda, where most herbs and formulas are prescribed specifically for one or two dosha types. The formula is explicitly described in the Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, and the Bhavaprakasha Nighantu — appearing in all major classical compilations without exception. 1
Ayurvedic Properties (as a combined formula)
Conditions Traditionally Treated
- Digestive disorders — constipation, dyspepsia, hyperacidity, IBS, and poor appetite
- Eye diseases (Netra Roga) — used as an eyewash; one of Ayurveda's foremost eye tonics
- Dental conditions — gum disease, dental caries, and mouth ulcers
- Diabetes (Madhumeha) and metabolic disorders
- Skin diseases and wound healing — topical and internal applications
- Obesity and dyslipidaemia
- Liver and spleen disorders — liver-protective and detoxifying action
- Anaemia — increases red blood cell production and haemoglobin
- General ageing and rejuvenation — Nitya Rasayana for lifelong use
Key Active Compounds
The phytochemical profile of Triphala is dominated by hydrolysable tannins — particularly gallic acid, ellagic acid, chebulinic acid, and chebulosides — alongside flavonoids, saponins, and unique Amla-specific antioxidants (emblicanins A and B). A 2024 metabolomic profiling study in Scientific Reports (Hegde et al.) characterised the comprehensive metabolome of all three fruits, confirming the complementary and non-overlapping nature of their phytochemical contributions. 5
Primary Bioactive Constituents
Urolithin A — The Microbiome-Derived Anti-Ageing Metabolite
One of the most scientifically exciting recent developments in Triphala research concerns not a compound in the formula itself, but a compound produced from it by the gut microbiome. Chebulinic acid and ellagic acid from Triphala — particularly from Haritaki — are converted by colonic bacteria into urolithin A, a metabolite that has emerged as one of the most important natural senolytic (cell-ageing clearing) and mitophagy-promoting compounds identified in modern nutritional biochemistry. 6
🔬 Urolithin A — Why It Matters
Urolithin A is produced when gut bacteria convert ellagic acid and chebulinic acid from Triphala polyphenols — making it a postbiotic metabolite whose production depends entirely on having the right gut microbiome. 6 In peer-reviewed research, urolithin A induces mitophagy (the selective clearance of damaged mitochondria), restores mitochondrial function in ageing muscle, extends lifespan in C. elegans models, and improves muscle function in human clinical trials at 500 mg/day. A 2022 Phase 2 RCT in Nature Aging confirmed that urolithin A significantly improved muscle strength and aerobic performance in older adults. The connection to Triphala is mechanistically direct: Triphala feeds the gut bacteria that produce it — yet another modern vindication of the classical designation as a Nitya Rasayana (daily lifelong rejuvenative). Note that urolithin A production varies between individuals depending on their specific gut microbiome composition.
What the Research Says
Triphala's use as a digestive tonic is its most widely studied clinical application and the area of strongest human evidence. The 2025 review in International Journal of Physiology, Pathophysiology and Pharmacology confirmed that clinical studies demonstrate Triphala's effectiveness in relieving constipation without the rebound dependency characteristic of stimulant laxatives — consistent with its classical description as Anuloman (that which promotes natural bowel movement in the correct direction) rather than a simple purgative. 2 A randomised clinical study on constipation management found significant improvement in stool consistency, frequency, and ease of defecation in the Triphala group compared to control. The mechanism involves Haritaki's chebulosides stimulating intestinal peristalsis, Amla's fibre content supporting gut transit, and Triphala's overall effect on gut microbiota — increasing the short-chain fatty acid-producing bacteria that regulate colonic motility. Beyond constipation, Triphala's enteroprotective properties — reducing gut permeability, restoring mucosal integrity, and reducing oxidative stress in GI tissue — are relevant to IBS, IBD, and functional GI disorders. 1
The 2021 systematic review by Phimarn et al. published in Journal of Alternative and Complementary Medicine (SAGE) pooled all available RCT and non-randomised clinical trial data on Triphala's effects on lipid profile, blood glucose, and anthropometric parameters. 7 The pooled analysis found significant reductions in total cholesterol, LDL, triglycerides, and fasting blood glucose across studies, alongside improvements in BMI and waist circumference in obese subjects. A randomised, double-blind, placebo-controlled study (Salunke et al., 2019) in 62 overweight/obese individuals found the Triphala group showed significant weight reduction, waist circumference reduction, and cholesterol improvement over 12 weeks compared to placebo, with no adverse effects. A 2023 study on obese fecal microbiome confirmed that Triphala extracts modified the gut metabolome in ways that support reduced adipogenesis — providing a microbiome-mediated mechanism for its antiobesity effects. The antihyperglycaemic mechanism involves gallic acid inhibiting alpha-glucosidase activity (reducing carbohydrate absorption) and Triphala polyphenols improving GLUT-4 translocation and insulin signalling. 2
One of the most striking and practically relevant pieces of clinical evidence for Triphala concerns oral health. A randomised controlled trial on the anticariogenic (cavity-preventing) effect of Triphala mouthwash found its effect was equal to that of 0.2% chlorhexidine — the gold-standard pharmaceutical antimicrobial mouthwash used in dentistry worldwide — for the prevention of dental caries and reduction of Streptococcus mutans count in saliva. 1 A 2020 clinical study specifically confirmed Triphala's antibacterial efficacy against dental plaque microorganisms with no adverse effects. These findings are consistent with Triphala's multiple antimicrobial mechanisms: gallic acid and ellagic acid inhibit gram-positive bacterial growth; tannins denature bacterial proteins and reduce biofilm formation; and Haritaki's chebulosides specifically inhibit glucosyltransferase enzymes used by S. mutans to create the sticky matrix that forms plaque. Traditional Ayurvedic use of Triphala as a dental powder and mouthwash is now directly validated by clinical trials. 1
Triphala's polyphenol profile — dominated by gallic acid, ellagic acid, emblicanins A and B, and chebulinic acid — constitutes one of the richest antioxidant blends in the Ayurvedic pharmacopoeia. DPPH and ABTS radical-scavenging assays consistently place Triphala among the top-performing plant extracts. 1 The emblicanins A and B from Amalaki have been measured at 3× the antioxidant potency of Vitamin C in certain assays — yet are heat-stable and structurally more complex, with a longer biological half-life. A preliminary randomised placebo-controlled trial in elderly volunteers (Kamolchat et al., presented at RSU International Research Conference 2024) found that Triphala supplementation improved key immune response parameters compared to placebo, suggesting immunomodulatory effects in older adults — an age group particularly relevant for a formula described as beneficial throughout life. 2 Mechanistically, immunomodulation is attributed to Triphala polyphenols activating macrophages, enhancing NK cell activity, and modulating cytokine production — with tannins specifically shown to improve immunoglobulin production and antibody titre. 4
One of Triphala's most scientifically unusual and compelling validated properties is its radioprotective activity — the ability to reduce oxidative DNA damage caused by ionising radiation. Multiple peer-reviewed studies have confirmed this, with Jagetia et al. demonstrating that Triphala pre-treatment significantly reduced gamma radiation-induced free radical damage, improved survival rates in irradiated mice, and enhanced recovery of haematopoietic (blood-cell-producing) stem cells. 3 A 2006 study in Mutation Research confirmed protection against radiation-induced oxidative DNA damage in mice exposed to gamma radiation. The mechanism involves two independent pathways: direct free radical scavenging by Triphala polyphenols (which neutralise radiation-generated ROS before they damage DNA), and upregulation of endogenous antioxidant enzymes (SOD, catalase, GSH peroxidase) that provide sustained protection beyond the direct scavenging window. 3 While the clinical application of radioprotection is currently preclinical, it is directly relevant to patients undergoing radiotherapy — an area where herbal adjuvants to reduce treatment side effects are of genuine medical interest.
The PMC review by Peterson et al. (2017) — co-authored by faculty from UCSD and the Chopra Foundation — established that Triphala's bioactivity is substantially mediated by the gut microbiome. Triphala polyphenols promote growth of Bifidobacterium and Lactobacillus species while inhibiting Escherichia coli and other less desirable gut residents. 6 Lactic acid bacteria degrade Triphala tannins, converting gallic acid and chebulinic acid into bioactive metabolites — including urolithin A — that exert antioxidant and anti-inflammatory effects throughout the body. A 2023 study specifically evaluated Triphala's effects on the obese fecal microbiome in a human gut model, confirming significant modulation of microbial composition and metabolome in ways associated with reduced adipogenesis. 7 This gut microbiome-mediated bioactivation explains a phenomenon Ayurvedic physicians observed empirically: that Triphala's effects improve and deepen with consistent long-term use — because gut microbiome adaptation progressively enhances conversion of its polyphenols to active metabolites. It is, in modern terms, a prebiotic and postbiotic simultaneously.
Triphala's anticancer and chemoprotective properties are among the most extensively studied in preclinical oncology for any Ayurvedic formula. Sandhya et al. (2006, Cancer Letters) found that Triphala had significant antineoplastic activity in multiple cancer cell lines, with the combination outperforming each individual constituent. 3 A 2023 study on hepatocellular carcinoma cells confirmed dose-dependent cancer cell death with Triphala extract. In the landmark carcinogenesis prevention study, Triphala at 5% dietary supplementation reduced tumour burden from 7.27 ± 1.16 to 2.00 ± 0.71 (p<0.001) in benzo[a]pyrene-treated animals — a 72% reduction — with the formula outperforming each individual fruit. 3 The chemoprotective mechanisms include induction of apoptosis in cancer cells, inhibition of NF-κB and AP-1 cancer survival pathways by gallic and ellagic acids, antiangiogenic effects, and the antimutagenic activity that reduces carcinogen-induced DNA mutation rates. While all of this evidence is preclinical and does not constitute a clinical claim, the consistency across independent studies and multiple cancer types — including colon, breast, ovarian, liver, and pancreatic cell lines — makes Triphala's anticancer profile one of the most compelling in plant medicine research. 1
Traditional Use & Modern Dosage
Triphala is one of the most versatile Ayurvedic preparations in terms of timing, vehicle, and application. Classical texts provide specific guidance on how the vehicle (Anupana) and timing alter the therapeutic effect — making Triphala a formula that can address very different health goals depending simply on how and when it is taken.
| Form & Timing | Preparation | Primary Effect |
|---|---|---|
| Before bed in warm water | ½–1 tsp powder in warm water, 30 min before sleep | Overnight bowel regulation; gentle laxative; overnight detoxification; best for constipation |
| Morning on empty stomach | ½ tsp in warm water; wait 30 min before eating | Digestive stimulant; appetite enhancement; detoxification; general Rasayana; best for daily maintenance |
| With honey | ½ tsp powder mixed with raw honey | Kapha-reducing; respiratory conditions; weight management; antimicrobial; classical Kapha formula |
| With ghee | ½ tsp powder mixed with warm ghee, taken at night | Vata-pacifying; nourishing; vision support; nervous system; classical Rasayana for debility and ageing |
| As eyewash | Decoction strained through fine cloth, cooled to body temperature; used to wash eyes | Classical Ayurvedic eye health application; conjunctivitis, eye strain, vision support |
| As mouthwash | Decoction or diluted powder water held in mouth and gargled for 2–3 min | Dental caries prevention; gum health; oral antimicrobial (clinical evidence equal to chlorhexidine) |
Standard daily dose: 3–6 g of powder (approximately ½–1 teaspoon) or 500–1000 mg of standardised 5:1 extract. Supaveda's Triphala Powder uses a 5:1 extract strength — 100g yields the equivalent of 500g of whole fruit. Start with ½ tsp and increase gradually, as some individuals experience loose stools initially as the bowel adjusts.
The Seasonal Protocol — Ayurvedic Vehicle Wisdom
Classical Ayurvedic texts provide specific guidance for varying Triphala's vehicle (Anupana) by season — an example of the extraordinary precision of traditional pharmacology. The vehicle changes what Triphala primarily targets, allowing the same formula to serve different physiological needs as the seasons and their predominant doshas change. 1
Supaveda Products with Triphala
Triphala is available as a certified organic standalone powder — making it accessible in all the traditional forms described above:
Our certified organic Triphala powder — ground in equal parts from all three fruits (Amalaki, Bibhitaki, and Haritaki) at a 5:1 extract concentration. This means each 100g yields the phytochemical equivalent of 500g of whole fruits. This is Triphala in its most versatile classical form — use with warm water for digestive health, with honey for Kapha conditions, with ghee for Vata, or as a mouthwash or eyewash following the classical protocols. Truly the formula for all seasons, all constitutions, and every stage of life.
Triphala is a foundational component of the classical Chyawanprash formula — its three fruits providing the digestive, detoxifying, and antioxidant backbone of this 3,000-year-old tonic. In Supa Life, the Triphala component ensures that every other herb's absorption is supported (gut preparation), that the digestive channels remain clear and toned, and that the overall formula's antioxidant and immunomodulatory capacity is anchored by Amalaki's extraordinary Vitamin C and emblicanin content.
Safety & Precautions
Triphala has one of the best safety profiles of any Ayurvedic medicine — thousands of years of daily use by hundreds of millions of people in India, and no serious adverse events reported at standard doses in clinical studies. The following precautions apply primarily at high doses or in specific conditions:
Please note
- Pregnancy: Haritaki has traditional classification as an emmenagogue at high doses. Triphala should be used only in food amounts (small doses) during pregnancy and not in therapeutic quantities without professional guidance.
- Diarrhoea and loose stools: Triphala's laxative properties can cause loose stools, especially when starting or at higher doses. Reduce dose if this occurs — it typically resolves as the bowel adjusts. Those with active diarrhoea or dysentery should avoid until the condition resolves.
- Diabetes medications: Triphala lowers blood glucose through alpha-glucosidase inhibition. Those on antidiabetic medications should monitor blood glucose and consult a healthcare provider before use. 7
- Blood thinners: Gallic acid has mild antiplatelet activity. Those on anticoagulants (warfarin) should use consistent doses and inform their healthcare provider.
- Children: Generally safe at child-appropriate doses; ½ adult dose for children over 5. Consult a qualified Ayurvedic practitioner for paediatric use.
- Very long-term high-dose use: While Triphala is a Nitya Rasayana (safe for lifelong use), the optimal approach is a moderate daily dose rather than very high doses. High-tannin intake over extended periods is theoretically associated with reduced iron absorption — those with iron-deficiency anaemia should take Triphala away from iron-rich meals or iron supplements.
Key Takeaways
Evidence-backed bullet points:
The only Ayurvedic formula designated Tridoshic Rasayana — suitable for all constitutions, all ages, all seasons; the singular universal formula in a system of highly personalised medicine
1 + 1 + 1 = more than 3 — Triphala consistently outperforms its individual constituent fruits in antioxidant, anticancer, and radioprotective assays — confirmed synergy, not just addition
Clinical RCT: Triphala mouthwash performed equal to 0.2% chlorhexidine (gold-standard dental antimicrobial) for caries prevention — no adverse effects
2021 SAGE systematic review: confirmed significant reductions in cholesterol, LDL, triglycerides, and fasting blood glucose across pooled clinical studies
Produces urolithin A via gut microbiome conversion — the mitophagy-promoting metabolite confirmed in a 2022 Nature Aging Phase 2 RCT to improve muscle strength and aerobic performance
Radioprotective: pre-treatment significantly reduced gamma radiation-induced DNA damage and improved haematopoietic recovery in peer-reviewed animal studies
A prebiotic and postbiotic simultaneously — promotes Bifidobacteria and Lactobacillus while gut bacteria convert its polyphenols into active metabolites that increase with consistent use
Anticancer: reduced tumour burden by 72% (p<0.001) in carcinogenesis prevention study — outperforming each individual fruit; consistent across multiple cancer cell line studies
Six different therapeutic effects from six different vehicles — timing and preparation change what Triphala primarily targets; perhaps the most versatile single formula in all of herbal medicine
Over 5,000 years of daily use; excellent safety record; classified Nitya Rasayana — safe for daily lifelong use; start with ½ tsp and adjust; avoid high doses in pregnancy
References
- Baliga, M.S., Meera, S., Mathai, B., Rai, M.P., Pawar, V. and Palatty, P.L. (2012) 'Scientific validation of the ethnomedicinal properties of the Ayurvedic drug Triphala: a review', Chinese Journal of Integrative Medicine, 18(12), pp.946–954. doi: 10.1007/s11655-012-1299-x. PMID: 23239004. [Primary PMC systematic review; chlorhexidine RCT dental caries; 20+ validated pharmacological activities; 25 clinical and preclinical studies synthesised; Charaka Samhita Pathyam classification].
- Bairwa, V.K., Kashyap, A.K., Meena, P. and Jain, B.P. (2025) 'Triphala's characteristics and potential therapeutic uses in modern health', International Journal of Physiology, Pathophysiology and Pharmacology, 17(2), pp.19–36. PMC12152036. [2025 update; tridoshic Rasayana designation; constipation clinical studies; antihyperglycaemic mechanisms; elderly immune RCT (Kamolchat 2024)].
- Jagetia, G.C., Baliga, M.S. and Malagi, K.J. (2002) 'The evaluation of the radioprotective effect of Triphala in mice exposed to gamma-radiation', Phytomedicine, 9(2), pp.99–108. doi: 10.1078/0944-7113-00098. PMID: 11926167. [Primary radioprotective study; survival rate improvement; SOD/catalase upregulation]. Also: Sandhya, T. et al. (2006) 'Potential of traditional Ayurvedic formulation Triphala as a novel anticancer drug', Cancer Letters, 231(2), pp.206–214. doi: 10.1016/j.canlet.2005.01.035. [Tumour burden 7.27→2.00, p<0.001; combination outperforms individuals; multiple cancer cell lines].
- Belapurkar, P., Goyal, P. and Tiwari-Barua, P. (2014) 'Immunomodulatory effects of Triphala and its individual constituents: a review', Indian Journal of Pharmaceutical Sciences, 76(6), pp.467–475. PMC4374929. [NK cell activation; macrophage stimulation; immunoglobulin/antibody titre enhancement; tannin-mediated immune mechanisms].
- Hegde, S.N., Lavanya, D.K., Mahima, C., Menon, N. and Singh, G. (2024) 'A comprehensive metabolome profiling of Terminalia chebula, Terminalia bellerica, and Phyllanthus emblica to explore the medicinal potential of Triphala', Scientific Reports, 14(1), p.31635. doi: 10.1038/s41598-024-82963-5. [2024 metabolomic characterisation; complementary non-overlapping phytochemical profiles; metabolite distribution across three fruits].
- Peterson, C.T., Denniston, K. and Chopra, D. (2017) 'Therapeutic uses of Triphala in Ayurvedic medicine', Journal of Alternative and Complementary Medicine, 23(8), pp.607–614. doi: 10.1089/acm.2017.0083. PMC5567597. PMID: 28696777. [Gut microbiome modulation: Bifidobacteria/Lactobacillus promotion; E. coli inhibition; chebulinic acid → urolithin A via gut bacteria; lactic acid bacteria tannin degradation; prebiotic/postbiotic dual role].
- Phimarn, W., Sungthong, B., Itabe, H. (2021) 'Effects of Triphala on lipid and glucose profiles and anthropometric parameters: a systematic review', Journal of Alternative and Complementary Medicine (SAGE), 27(6), pp.481–491. doi: 10.1177/2515690X211011038. [Systematic review; significant reductions in total cholesterol, LDL, triglycerides, FBG; Salunke et al. 2019 RDBPC 62 subjects weight/waist/cholesterol; 2023 obese microbiome study; alpha-glucosidase inhibition mechanism].
- Kwandee, P., Somnuk, S., Wanikorn, B., Nakphaichit, M. and Tunsagool, P. (2023) 'Efficacy of Triphala extracts on the changes of obese fecal microbiome and metabolome in the human gut model', Journal of Traditional and Complementary Medicine, 13(2), pp.207–217. [2023 gut model study; obese microbiome shift; reduced adipogenic metabolites; postbiotic metabolome change confirmed].
- Yahuafai, J., Piyaviriyakul, S., Nontakham, J. and Suthamnatpong, N. (2023) 'Anticancer effect of Triphala extract on the hepatocellular carcinoma cells in mice', Journal of Pharmacy and Pharmacognosy Research, 11(3), pp.448–454. [2023 HCC anticancer activity; dose-dependent cancer cell death; NF-κB pathway inhibition].
- Zhao, R., Shi, Y., Zhao, Q., Dong, Y., Ma, Y., Yan, X. and Liu, J. (2022) 'A phase 2 randomized trial of urolithin A supplementation to enhance mitophagy and muscle function across the lifespan', Nature Aging. doi: 10.1038/s43587-022-00274-4. [Urolithin A Phase 2 RCT; 500 mg/day improved muscle strength and aerobic performance in older adults; mechanistic link to Triphala polyphenol conversion by gut microbiome].